Disclosed positions

Estimated from their latest filings — positions may have changed since

$91.9K

combined est. value

Stock	Shares	Price	Value	Weight	As of
TCRTAlaunos Therapeutics, Inc.	47,642	$1.93	$91.9K	100%	2026-07-23

TCRT

Alaunos Therapeutics, Inc.

$91.9K

47,642 sh

All filings on record

Every Form 4 transaction we track for this filer

all 5buys 0sells 0

Stock	Transaction	Date	~6mo later
TCRTAlaunos Therapeutics, Inc.	Grant $16.9K · 8,789 sh	2026-07-23	—
MLACRMountain Lake Acquisition Corp.	Return — · 478,010 sh	2026-06-11	—
TCRTAlaunos Therapeutics, Inc.	Grant $16.9K · 5,839 sh	2026-01-12	—
TCRTAlaunos Therapeutics, Inc.	Grant $16.9K · 5,340 sh	2025-11-21	—
TCRTAlaunos Therapeutics, Inc.	Grant — · 3,400 sh	2025-07-03	—

TCRTGrant

2026-07-23 · Alaunos Therapeutics, Inc.

$16.9K

—

MLACRReturn

2026-06-11 · Mountain Lake Acquisition Corp.

478,010

—

TCRTGrant

2026-01-12 · Alaunos Therapeutics, Inc.

$16.9K

—

TCRTGrant

2025-11-21 · Alaunos Therapeutics, Inc.

$16.9K

—

TCRTGrant

2025-07-03 · Alaunos Therapeutics, Inc.

3,400

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.